Single nucleotide polymorphisms affecting galantamine binding to acetylcholinesterase in Alzheimer's disease: a structural bioinformatics study. [PDF]
Islam N, Akçesme B.
europepmc +1 more source
Design and Physicochemical Characterization of Hybrid PLGA-Curcumin/Carbon Dot Nanoparticles for Sustained Galantamine Release: A Proof-of-Concept Study. [PDF]
Samiotaki C +6 more
europepmc +1 more source
Antiglycative Properties of Anti-Dementia Drugs-In Vitro, In Silico Studies and a Systematic Literature Review. [PDF]
Orlof W +5 more
europepmc +1 more source
Dynamic associations of cholinesterase inhibitors and memantine with cognitive trajectories in individuals with Alzheimer's or mixed dementia: a real-world analysis using the quality registry SveDem. [PDF]
Chen C +5 more
europepmc +1 more source
Structural and Mechanistic Insights into Dual Cholinesterase Inhibition by Marine Phytohormones. [PDF]
Youn K, Soriano LM, Jun M.
europepmc +1 more source
Medicinal compounds and biotechnology of Amaryllidaceae alkaloids in <i>Lycoris radiata</i>. [PDF]
Chen JX +9 more
europepmc +1 more source
Differential cognitive enhancer effects of acetylcholinesterase inhibitors and memantine on age-related deficits in vigilance and sustained attention: a preclinical validation study. [PDF]
Bali ZK +3 more
europepmc +1 more source
The cholinergic drug galantamine ameliorates acute and subacute peripheral and brain manifestations of acute respiratory distress syndrome in mice. [PDF]
Falvey A +10 more
europepmc +1 more source
Use of anti-dementia drugs in home care and residential care and associations with neuropsychiatric symptoms: a cross-sectional study [PDF]
core +1 more source
Cholinesterase inhibitors for patients with dementia: Patterns of prescribing and disparities in treatment. [PDF]
Heo RJ +8 more
europepmc +1 more source

